JPMORGAN CHASE & CO - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$4,519,280
-6.5%
292,132
-5.0%
0.00%
-100.0%
Q2 2023$4,831,312
+295.4%
307,531
+315.0%
0.00%
Q1 2023$1,221,780
+462695.5%
74,108
+337.4%
0.00%
Q4 2022$264
-99.9%
16,942
-5.5%
0.00%
Q3 2022$233,000
-2.5%
17,936
+5.2%
0.00%
Q2 2022$239,000
-3.6%
17,052
-1.6%
0.00%
Q1 2022$248,000
+4.6%
17,331
-0.5%
0.00%
Q4 2021$237,000
-23.8%
17,425
-8.4%
0.00%
Q3 2021$311,000
-21.5%
19,021
-19.1%
0.00%
Q2 2021$396,000
-91.8%
23,508
-91.1%
0.00%
-100.0%
Q1 2021$4,818,000
+479.8%
263,854
+477.9%
0.00%
Q4 2020$831,000
-76.2%
45,661
-76.3%
0.00%
-100.0%
Q3 2020$3,488,000
+56.9%
192,280
+55.2%
0.00%
Q2 2020$2,223,000
-19.0%
123,922
-31.5%
0.00%
-100.0%
Q1 2020$2,746,000
+156.6%
180,883
+233.5%
0.00%
Q4 2019$1,070,000
+147.1%
54,237
+115.1%
0.00%
Q3 2019$433,000
-3.8%
25,211
-1.8%
0.00%
Q2 2019$450,000
-13.5%
25,661
+0.6%
0.00%
Q1 2019$520,000
-55.3%
25,518
-63.1%
0.00%
Q4 2018$1,163,00069,1780.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders